Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension

Interventional activation of the carotid baroreflex has been an appealing idea for the management of resistant hypertension for several decades, yet its clinical application remained elusive and a goal for the future. It is only recently that the profound understanding of the complex anatomy and pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Vasilios Papademetriou, Michael Doumas, Charles Faselis, Constantinos Tsioufis, Stella Douma, Eugene Gkaliagkousi, Chrysanthos Zamboulis
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.4061/2011/964394
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550298146570240
author Vasilios Papademetriou
Michael Doumas
Charles Faselis
Constantinos Tsioufis
Stella Douma
Eugene Gkaliagkousi
Chrysanthos Zamboulis
author_facet Vasilios Papademetriou
Michael Doumas
Charles Faselis
Constantinos Tsioufis
Stella Douma
Eugene Gkaliagkousi
Chrysanthos Zamboulis
author_sort Vasilios Papademetriou
collection DOAJ
description Interventional activation of the carotid baroreflex has been an appealing idea for the management of resistant hypertension for several decades, yet its clinical application remained elusive and a goal for the future. It is only recently that the profound understanding of the complex anatomy and pathophysiology of the circuit, combined with the accumulation of relevant experimental and clinical data both in animals and in humans, has allowed the development of a more effective and well-promising approach. Indeed, current data support a sustained over a transient reduction of blood pressure through the resetting of baroreceptors, and technical deficits have been minimized with a subsequent recession of adverse events. In addition, clinical outcomes from the application of a new implantable device (Rheos) that induces carotid baroreceptor stimulation point towards a safe and effective blood pressure reduction, but longer experience is needed before its integration in the everyday clinical practice. While accumulating evidence indicates that carotid baroreceptor stimulation exerts its benefits beyond blood pressure reduction, further research is necessary to assess the spectrum of beneficial effects and evaluate potential hazards, before the extraction of secure conclusions.
format Article
id doaj-art-a3a22a0e08ac4b8793e1e237a94320da
institution Kabale University
issn 2090-0392
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-a3a22a0e08ac4b8793e1e237a94320da2025-02-03T06:07:13ZengWileyInternational Journal of Hypertension2090-03922011-01-01201110.4061/2011/964394964394Carotid Baroreceptor Stimulation for the Treatment of Resistant HypertensionVasilios Papademetriou0Michael Doumas1Charles Faselis2Constantinos Tsioufis3Stella Douma4Eugene Gkaliagkousi5Chrysanthos Zamboulis6Veterans Affairs Medical Center, Georgetown University, Washington, DC 20422, USAVeterans Affairs Medical Center, George Washington University, Washington, DC 20037, USAVeterans Affairs Medical Center, George Washington University, Washington, DC 20037, USAVeterans Affairs Medical Center, Georgetown University, Washington, DC 20422, USA2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 54643 Thessaloniki, Greece2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 54643 Thessaloniki, Greece2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, 54643 Thessaloniki, GreeceInterventional activation of the carotid baroreflex has been an appealing idea for the management of resistant hypertension for several decades, yet its clinical application remained elusive and a goal for the future. It is only recently that the profound understanding of the complex anatomy and pathophysiology of the circuit, combined with the accumulation of relevant experimental and clinical data both in animals and in humans, has allowed the development of a more effective and well-promising approach. Indeed, current data support a sustained over a transient reduction of blood pressure through the resetting of baroreceptors, and technical deficits have been minimized with a subsequent recession of adverse events. In addition, clinical outcomes from the application of a new implantable device (Rheos) that induces carotid baroreceptor stimulation point towards a safe and effective blood pressure reduction, but longer experience is needed before its integration in the everyday clinical practice. While accumulating evidence indicates that carotid baroreceptor stimulation exerts its benefits beyond blood pressure reduction, further research is necessary to assess the spectrum of beneficial effects and evaluate potential hazards, before the extraction of secure conclusions.http://dx.doi.org/10.4061/2011/964394
spellingShingle Vasilios Papademetriou
Michael Doumas
Charles Faselis
Constantinos Tsioufis
Stella Douma
Eugene Gkaliagkousi
Chrysanthos Zamboulis
Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
International Journal of Hypertension
title Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
title_full Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
title_fullStr Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
title_full_unstemmed Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
title_short Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
title_sort carotid baroreceptor stimulation for the treatment of resistant hypertension
url http://dx.doi.org/10.4061/2011/964394
work_keys_str_mv AT vasiliospapademetriou carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT michaeldoumas carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT charlesfaselis carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT constantinostsioufis carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT stelladouma carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT eugenegkaliagkousi carotidbaroreceptorstimulationforthetreatmentofresistanthypertension
AT chrysanthoszamboulis carotidbaroreceptorstimulationforthetreatmentofresistanthypertension